Back to Search
AMINAH JATOI, M.D.
M.D.
Medical Oncology Physician
NPI: 1437136553Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
35937(MN)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).
PMID 19665818·Lung Cancer·2010
2-rct
Bisphosphonates: preventing skeletal morbidity and maybe doing more.
PMID 19508828·Curr Oncol Rep·2009
8-other
Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147.
PMID 19622902·Oncology·2009
3-trial
In search of rigorous data on how to palliate the EGFR inhibitor-induced rash.
PMID 19323303·Oncology (Williston Park)·2009
8-other
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).
PMID 18449005·J Thorac Oncol·2008
3-trial
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).
PMID 18543329·Cancer·2008
3-trial
Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy.
PMID 18988655·Oncologist·2008
1-meta
Weight loss in patients with advanced cancer: effects, causes, and potential management.
PMID 18685394·Curr Opin Support Palliat Care·2008
6-review
Side effects and pharmaceutical company bias: adverse event reporting in cancer supportive and palliative care trials.
PMID 19012496·Expert Opin Investig Drugs·2008
8-other
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044).
PMID 17921712·Am J Clin Oncol·2007
3-trial
Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort.
PMID 18165623·Oncologist·2007
4-observational
Sunshine and rash: testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash.
PMID 18632517·Support Cancer Ther·2007
8-other
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.
PMID 17320666·Urology·2007
3-trial
A critical look at the role of chemotherapy in older patients with non-small cell lung cancer.
PMID 17410017·J Thorac Oncol·2007
6-review
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
PMID 17674351·Cancer·2007
2-rct
Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.
PMID 17265786·J Support Oncol·2007
8-other
Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across Minnesota.
PMID 17094362·Minn Med·2006
8-other
The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer.
PMID 16866854·Dis Esophagus·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1437136553
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile